These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 27194536)

  • 21. Misidentification of recombinant hepatitis C virus leading to treatment failure with direct acting antivirals.
    Mourez T; Decroos A; Goria O; Montialoux H; De Oliveira F; Larrat S; Plantier JC; Riachi G
    J Med Virol; 2018 May; 90(5):994-997. PubMed ID: 29350410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in the epidemiology of hepatitis C infection in Germany: shift in the predominance of hepatitis C subtypes.
    Ross RS; Viazov S; Renzing-Köhler K; Roggendorf M
    J Med Virol; 2000 Feb; 60(2):122-5. PubMed ID: 10596009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C Virus p7 membrane protein quasispecies variability in chronically infected patients treated with interferon and ribavirin, with or without amantadine.
    Castelain S; Bonte D; Penin F; François C; Capron D; Dedeurwaerder S; Zawadzki P; Morel V; Wychowski C; Duverlie G
    J Med Virol; 2007 Feb; 79(2):144-54. PubMed ID: 17177298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels.
    Di Maio VC; Cento V; Di Paolo D; Aragri M; De Leonardis F; Tontodonati M; Micheli V; Bellocchi MC; Antonucci FP; Bertoli A; Lenci I; Milana M; Gianserra L; Melis M; Di Biagio A; Sarrecchia C; Sarmati L; Landonio S; Francioso S; Lambiase L; Nicolini LA; Marenco S; Nosotti L; Giannelli V; Siciliano M; Romagnoli D; Pellicelli A; Vecchiet J; Magni CF; Babudieri S; Mura MS; Taliani G; Mastroianni C; Vespasiani-Gentilucci U; Romano M; Morisco F; Gasbarrini A; Vullo V; Bruno S; Baiguera C; Pasquazzi C; Tisone G; Picciotto A; Andreoni M; Parruti G; Rizzardini G; Angelico M; Perno CF; Ceccherini-Silberstein F;
    J Antimicrob Chemother; 2016 Mar; 71(3):739-50. PubMed ID: 26679249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HCV NS3 quasispecies in liver and plasma and dynamics of telaprevir-resistant variants in breakthrough patients assessed by UDPS: A case study.
    Bartolini B; Selleri M; Garbuglia AR; Giombini E; Taibi C; Lionetti R; D'Offizi G; Capobianchi MR
    J Clin Virol; 2015 Nov; 72():60-5. PubMed ID: 26418073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Development of "Amplisens-HCV-genotype" reagent set for identification of hepatitis C virus genotypes 1a, 1b, 2a and 3a].
    Gushchin AE; Hoskova OM; Shipulin GA
    Vopr Virusol; 2003; 48(3):45-8. PubMed ID: 12894481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Next-Generation Sequencing of 5' Untranslated Region of Hepatitis C Virus in Search of Minor Viral Variant in a Patient Who Revealed New Genotype While on Antiviral Treatment.
    Caraballo Cortes K; Bukowska-Ośko I; Pawełczyk A; Perlejewski K; Płoski R; Lechowicz U; Stawiński P; Demkow U; Laskus T; Radkowski M
    Adv Exp Med Biol; 2016; 885():11-23. PubMed ID: 26747069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HCV genotypes, characterization of mutations conferring drug resistance to protease inhibitors, and risk factors among blood donors in São Paulo, Brazil.
    Nishiya AS; de Almeida-Neto C; Ferreira SC; Alencar CS; Di-Lorenzo-Oliveira C; Levi JE; Salles NA; Mendrone A; Sabino EC
    PLoS One; 2014; 9(1):e86413. PubMed ID: 24466079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic variability of hepatitis B and C viruses in Brazilian patients with and without hepatocellular carcinoma.
    Araujo OC; Barros JJ; do Ó KM; Nabuco LC; Luz CA; Perez RM; Niel C; Villela-Nogueira CA; Araujo NM
    J Med Virol; 2014 Feb; 86(2):217-23. PubMed ID: 24338810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant hepatitis C virus in experimentally infected chimpanzees.
    Gao F; Nainan OV; Khudyakov Y; Li J; Hong Y; Gonzales AC; Spelbring J; Margolis HS
    J Gen Virol; 2007 Jan; 88(Pt 1):143-147. PubMed ID: 17170446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conservation of hepatitis C virus nonstructural protein 3 amino acid sequence in viral isolates during liver transplantation.
    Mello IM; Thumann C; Schvoerer E; Soulier E; Pinho JR; Silvestre DA; Queiroz AT; Wolf P; Baumert TF; Keller FS; Pereira CA
    J Viral Hepat; 2009 Oct; 16(10):732-7. PubMed ID: 19486468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Near full length hepatitis C virus genome reconstruction by next generation sequencing based on genotype-independent amplification.
    Bartolini B; Giombini E; Abbate I; Selleri M; Rozera G; Biagini T; Visco-Comandini U; Taibi C; Capobianchi MR
    Dig Liver Dis; 2015 Jul; 47(7):608-12. PubMed ID: 25888234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Analysis of hepatitis C virus genotypes in Guizhou area, using second generation line probe assay].
    Ding J; Li Y; Tian M
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Sep; 13(3):243-6. PubMed ID: 12569755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distribution of HCV Genotypes in Tianjin, China and Characterization of a Full-Length Viral Genome Representing Subtype 6xa.
    Hou W
    Clin Lab; 2019 Aug; 65(8):. PubMed ID: 31414745
    [No Abstract]   [Full Text] [Related]  

  • 35. Analysis of hepatitis C virus core encoding sequences in chronically infected patients reveals mutability, predominance, genetic history and potential impact on therapy of Cuban genotype 1b isolates.
    González-Horta EE; Marante J; Amador-Cañizares Y; Alvarez-Lajonchere L; Guerra I; Martínez-Donato G; Dueñas-Carrera S
    Eur Rev Med Pharmacol Sci; 2011 Nov; 15(11):1320-7. PubMed ID: 22195367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel standardized deep sequencing-based assay for hepatitis C virus genotype determination.
    Rodriguez C; Soulier A; Demontant V; Poiteau L; Mercier-Darty M; Bouvier-Alias M; Pawlotsky JM; Chevaliez S
    Sci Rep; 2018 Mar; 8(1):4180. PubMed ID: 29520035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for two phylogenetic clusters within hepatitis C virus (HCV) genotype 2 inferred from analysis of complete coding sequences of 15 HCV strains.
    Jordier F; Deligny ML; Barré R; De Micco P; Cantaloube JF
    J Med Virol; 2013 Oct; 85(10):1754-64. PubMed ID: 23861126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low frequency of drug-resistant virus did not affect the therapeutic efficacy in daclatasvir plus asunaprevir therapy in patients with chronic HCV genotype-1 infection.
    Kinugasa H; Ikeda F; Takaguchi K; Mori C; Matsubara T; Shiraha H; Takaki A; Iwasaki Y; Toyooka S; Yamamoto K
    Antivir Ther; 2016; 21(1):37-44. PubMed ID: 26115551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiology of hepatitis C virus infections in Łódzkie voivodeship.
    Berkan-Kawińska A; Piekarska A; Koślińska-Berkan E; Deroń Z; Jabłkowski M; Wójcik K
    Przegl Epidemiol; 2016; 70(4):539-548. PubMed ID: 28213981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis C genotypes and subtypes in Saudi Arabia.
    Shobokshi OA; Serebour FE; Skakni L; Al-Saffy YH; Ahdal MN
    J Med Virol; 1999 May; 58(1):44-8. PubMed ID: 10223544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.